Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mookerjee

Showing results (391-400 of 461) with videos related to

Pageof 47
Sort By:
British Journal of Clinical Pharmacology|December 16, 2017
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600-mutant tumoursNoelia Nebot, Hendrik-Tobias Arkenau, Jeffrey R Infante, et al.
Alimentary Pharmacology & Therapeutics|June 12, 2020
Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathySigne Wiese, Andrei Voiosu, Jens D Hove, et al.
Frontiers in Immunology|June 2, 2023
Cellular activation pathways and interaction networks in vascularized composite allotransplantationLeonard Knoedler, Samuel Knoedler, Adriana C Panayi, et al.
International Journal of Surgery (London, England)|December 5, 2023
Racial disparities in surgical outcomes after mastectomy in 223 000 female breast cancer patients: a retrospective cohort studySamuel Knoedler, Martin Kauke-Navarro, Leonard Knoedler, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 17, 2012
Nitric oxide and L-arginine metabolism in a devascularized porcine model of acute liver failureVikram Sharma, Gabriella A M Ten Have, Lars Ytrebo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 4, 2014
Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinomaFatma E Mohamed, Rajai M Al-Jehani, Shane S Minogue, et al.
Cancer|November 22, 2013
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyureaSrdan Verstovsek, Francesco Passamonti, Alessandro Rambaldi, et al.
Bone Marrow Transplantation|August 6, 2003
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patientsT Hahn, C Rondeau, A Shaukat, et al.
JHEP Reports : Innovation in Hepatology|June 9, 2026
Alpha 2A adrenergic receptor antagonism reduces fibrosis, inflammation and portal hypertension in models of chronic liver diseaseKaren Louise Thomsen, Vikram Sharma, Helen Jones, et al.
Nature Medicine|July 4, 2019
Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanomaAntoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
Pageof 47

Showing results (391-400 of 461) with videos related to

Sort By:
Pageof 47
British Journal of Clinical Pharmacology|December 16, 2017
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600-mutant tumoursNoelia Nebot, Hendrik-Tobias Arkenau, Jeffrey R Infante, et al.
Alimentary Pharmacology & Therapeutics|June 12, 2020
Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathySigne Wiese, Andrei Voiosu, Jens D Hove, et al.
Frontiers in Immunology|June 2, 2023
Cellular activation pathways and interaction networks in vascularized composite allotransplantationLeonard Knoedler, Samuel Knoedler, Adriana C Panayi, et al.
International Journal of Surgery (London, England)|December 5, 2023
Racial disparities in surgical outcomes after mastectomy in 223 000 female breast cancer patients: a retrospective cohort studySamuel Knoedler, Martin Kauke-Navarro, Leonard Knoedler, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 17, 2012
Nitric oxide and L-arginine metabolism in a devascularized porcine model of acute liver failureVikram Sharma, Gabriella A M Ten Have, Lars Ytrebo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 4, 2014
Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinomaFatma E Mohamed, Rajai M Al-Jehani, Shane S Minogue, et al.
Cancer|November 22, 2013
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyureaSrdan Verstovsek, Francesco Passamonti, Alessandro Rambaldi, et al.
Bone Marrow Transplantation|August 6, 2003
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patientsT Hahn, C Rondeau, A Shaukat, et al.
JHEP Reports : Innovation in Hepatology|June 9, 2026
Alpha 2A adrenergic receptor antagonism reduces fibrosis, inflammation and portal hypertension in models of chronic liver diseaseKaren Louise Thomsen, Vikram Sharma, Helen Jones, et al.
Nature Medicine|July 4, 2019
Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanomaAntoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
Pageof 47